SS
IMVT icon

SBI Securities’s Immunovant IMVT Stock Holding History

SBI Securities’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.36K Sell
139
-2
-1% -$61 ﹤0.01% 2144
2026
Q1 		$3.5K Buy
141
+28
+25% +$725 ﹤0.01% 2188
2025
Q4 		$2.87K Sell
113
-16
-12% -$357 ﹤0.01% 2256
2025
Q3 		$2.08K Hold
129
– – ﹤0.01% 2407
2025
Q2 		$2.06K Buy
129
+20
+18% +$302 ﹤0.01% 2371
2025
Q1 		$1.86K Sell
109
-1
-0.9% -$21 ﹤0.01% 2321
2024
Q4 		$2.73K Buy
+110
New +$3.12K ﹤0.01% 2177

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's IMVT Position: Q2 2026 in Review

SBI Securities reduced its Immunovant (IMVT) stake by 1.4% in Q2 2026, selling an estimated $61 and leaving 139 shares worth $5.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2144.

SBI Securities first reported a position in IMVT in Q4 2024 and has held it in 7 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • SBI Securities held 139 shares of Immunovant worth $5.36K as of Q2 2026.
  • SBI Securities sold 2 Immunovant shares in Q2 2026, an estimated $61.
  • Immunovant made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2144 holding.
  • SBI Securities first reported a position in Immunovant in Q4 2024 and has held it in 7 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.